InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.07
(
0.90%
)
US TECH 100
19,476.00
(
1.10%
)
Dow Jones
42,352.75
(
0.81%
)
Brent Oil
77.97
(
0.00%
)
Bitcoin
62,480.90
(
0.65%
)
Post# of 233596
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

llh222

Send PM Follow Ignore
Followers 38
Posts 1432
Boards Moderated 0
Alias Born 06/25/2009

llh222

Re: studhoss post# 84515

Sunday, 06/14/2020 2:32:09 AM

Sunday, June 14, 2020 2:32:09 AM

Post# of 233596
From what I have seen is lenzilumab blocks the L6 receptor ( whatever that is ) so has similar results to leronlimab in many cases. Since lenzilumab got a cash infussion of 72 Mil they may be in better shape financially at this time. I have not seen where lenzilumab is in any other trials so leronlimab holds the advantage there with the HIV, Cancer, and NASH possibilities. A good article to compare them is https://seekingalpha.com/article/4351875-covidminus-19-therapeutics-leading-contenders Is most honest S.A. article I have seen in a long time. Check out disclaimer at end of article. I agree that CYDY is the better bet at this time.

GLTA

LLH
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM

Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM

Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM

Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM

SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM

Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM

Start posting your company's news
Only $200 per official company press release!